Skip to main content
Top
Published in: Supportive Care in Cancer 1/2018

01-01-2018 | Original Article

Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals’ attitudes to and experience with scalp cooling

Authors: Joanne M. Shaw, Jane O’Brien, Susan Chua, Richard De Boer, Rachel Dear, Nicholas Murray, Fran Boyle

Published in: Supportive Care in Cancer | Issue 1/2018

Login to get access

Abstract

Background

Chemotherapy-induced alopecia is a common and distressing adverse event for patients. Scalp cooling to reduce this alopecia has been available in Europe for more than a decade, but only recently introduced in Australia. The aim of this study was to qualitatively explore health professionals’ perceptions of the barriers and enablers to the implementation of scalp cooling in Australian cancer centres.

Methods

Using a qualitative methodology, telephone interviews were conducted with 21 health professionals working in a tumour stream where chemotherapy-induced alopecia is an adverse event of treatment. Participants were recruited from five centres in Australia where scalp cooling is currently available and one centre without access to the technology.

Results

Four interrelated themes were identified: (1) health professional attitudes, (2) concerns for patient equity, (3) logistical considerations and (4) organisational support.

Conclusions

This qualitative study provides the first methodological exploration of Australian health professionals’ perceptions of barriers and enablers to scalp cooling uptake. The results highlighted health professional support drives the introduction of scalp cooling. Integration of the technology requires adjustments to nursing practice to manage the increased time, workload and change in patient flow. Strategies to manage the change in practice and organisational support for change in work flow are essential for successful implementation into routine care.
Literature
1.
go back to reference McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283–289CrossRef McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283–289CrossRef
2.
go back to reference Mulders M, Vingerhoets A, Breed W (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 12:97–102CrossRef Mulders M, Vingerhoets A, Breed W (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 12:97–102CrossRef
3.
go back to reference Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 17:317–328CrossRef Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psycho-Oncology 17:317–328CrossRef
4.
go back to reference Shaw J, Baylock B, O’Reilly A et al (2016) Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Supp Care Cancer 24:3813CrossRef Shaw J, Baylock B, O’Reilly A et al (2016) Scalp cooling: a qualitative study to assess the perceptions and experiences of Australian patients with breast cancer. Supp Care Cancer 24:3813CrossRef
5.
go back to reference Jayde V, Boughton M, Blomfield P (2013) The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer. Eur J Cancer Care 22:503–512CrossRef Jayde V, Boughton M, Blomfield P (2013) The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer. Eur J Cancer Care 22:503–512CrossRef
6.
go back to reference van den Hurk CJG, Winstanley J, Young A, Boyle F (2015) Measurement of chemotherapy-induced alopecia—time to change. Supp Care Cancer 23:1197–1199CrossRef van den Hurk CJG, Winstanley J, Young A, Boyle F (2015) Measurement of chemotherapy-induced alopecia—time to change. Supp Care Cancer 23:1197–1199CrossRef
7.
go back to reference Protière C, Evans K, Camerlo J, d'Ingrado MP, Macquart-Moulin G, Viens P, Genre D (2002) Efficacy and tolerance of a scalp-cooling system for prevention of alopecia and the experience of breast cancer patients treated by adjuvant chemotherapy. Supp care cancer 10:529–537CrossRef Protière C, Evans K, Camerlo J, d'Ingrado MP, Macquart-Moulin G, Viens P, Genre D (2002) Efficacy and tolerance of a scalp-cooling system for prevention of alopecia and the experience of breast cancer patients treated by adjuvant chemotherapy. Supp care cancer 10:529–537CrossRef
8.
go back to reference van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JWW, Breed WP (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-results of the Dutch scalp cooling registry. Acta Oncol 51:497–504CrossRef van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JWW, Breed WP (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-results of the Dutch scalp cooling registry. Acta Oncol 51:497–504CrossRef
9.
go back to reference Betticher DC, Delmore G, Breitenstein U, Anchisi S, Zimmerli-Schwab B, Müller A, Trueb RR (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Supp Care Cancer 21:2565–2573CrossRef Betticher DC, Delmore G, Breitenstein U, Anchisi S, Zimmerli-Schwab B, Müller A, Trueb RR (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Supp Care Cancer 21:2565–2573CrossRef
10.
go back to reference Breed WP, van den Hurk CJG, Peerbooms M (2011) Presentation, impact and prevention of chemotherapy-induced alopecia: scalp cooling potentials and limitations. Expert Rev Dermatol 6:109–125CrossRef Breed WP, van den Hurk CJG, Peerbooms M (2011) Presentation, impact and prevention of chemotherapy-induced alopecia: scalp cooling potentials and limitations. Expert Rev Dermatol 6:109–125CrossRef
11.
go back to reference Shin H, Jo SJ, Kim DH, Kwon O, Myung SK (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136:E442–E454CrossRef Shin H, Jo SJ, Kim DH, Kwon O, Myung SK (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136:E442–E454CrossRef
13.
go back to reference van den Hurk CJG, Breed WPM, Nortier JWR (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 20:3255–3260CrossRef van den Hurk CJG, Breed WPM, Nortier JWR (2012) Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 20:3255–3260CrossRef
14.
go back to reference Mols F, van den Hurk CJ, Vingerhoets AJ, Breed WP (2009) Scalp cooling to prevent chemotherapy-induced alopecia: practical and clinical considerations. Supp Care Cancer 17:181–189CrossRef Mols F, van den Hurk CJ, Vingerhoets AJ, Breed WP (2009) Scalp cooling to prevent chemotherapy-induced alopecia: practical and clinical considerations. Supp Care Cancer 17:181–189CrossRef
15.
go back to reference Kitson A, Harvey G, McCormack B (1998) Enabling the implementation of evidence based practice: a conceptual framework. Qual Health Care 7:149–158CrossRef Kitson A, Harvey G, McCormack B (1998) Enabling the implementation of evidence based practice: a conceptual framework. Qual Health Care 7:149–158CrossRef
16.
go back to reference Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N (2006) Lost in knowledge translation: time for a map? J Contin Educ Health Prof 26:13–24CrossRef Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N (2006) Lost in knowledge translation: time for a map? J Contin Educ Health Prof 26:13–24CrossRef
17.
go back to reference Corbin J, Strauss A Basics of qualitative research. Techniques and procedures for developing grounded theory. 3 ed. 2008. Thousand Oaks: Sage Pubications Inc Corbin J, Strauss A Basics of qualitative research. Techniques and procedures for developing grounded theory. 3 ed. 2008. Thousand Oaks: Sage Pubications Inc
18.
go back to reference Peerbooms M, van den Hurk C, Breed B (2015) Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals. Asia-Pacific J Oncol Nurs 2:35–41CrossRef Peerbooms M, van den Hurk C, Breed B (2015) Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals. Asia-Pacific J Oncol Nurs 2:35–41CrossRef
19.
go back to reference van den Hurk CJ, van den Akker-van Marle ME, Breed WP et al (2014) Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia. Acta Oncol 53:80–87CrossRef van den Hurk CJ, van den Akker-van Marle ME, Breed WP et al (2014) Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia. Acta Oncol 53:80–87CrossRef
Metadata
Title
Barriers and enablers to implementing scalp cooling in Australia: a qualitative study of health professionals’ attitudes to and experience with scalp cooling
Authors
Joanne M. Shaw
Jane O’Brien
Susan Chua
Richard De Boer
Rachel Dear
Nicholas Murray
Fran Boyle
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3849-7

Other articles of this Issue 1/2018

Supportive Care in Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine